Cargando…
Response to “A clinical trial is a success, not a failure, if it does not demonstrate efficacy or does identify safety concerns,” by Simon Kolstoe, Hugh Davies, and Janet Messer
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258805/ https://www.ncbi.nlm.nih.gov/pubmed/30511030 http://dx.doi.org/10.1016/j.conctc.2018.10.005 |
| _version_ | 1783374562494251008 |
|---|---|
| author | Fogel, David B. |
| author_facet | Fogel, David B. |
| author_sort | Fogel, David B. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6258805 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-62588052018-12-03 Response to “A clinical trial is a success, not a failure, if it does not demonstrate efficacy or does identify safety concerns,” by Simon Kolstoe, Hugh Davies, and Janet Messer Fogel, David B. Contemp Clin Trials Commun Article Elsevier 2018-10-22 /pmc/articles/PMC6258805/ /pubmed/30511030 http://dx.doi.org/10.1016/j.conctc.2018.10.005 Text en © 2018 Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Article Fogel, David B. Response to “A clinical trial is a success, not a failure, if it does not demonstrate efficacy or does identify safety concerns,” by Simon Kolstoe, Hugh Davies, and Janet Messer |
| title | Response to “A clinical trial is a success, not a failure, if it does not demonstrate efficacy or does identify safety concerns,” by Simon Kolstoe, Hugh Davies, and Janet Messer |
| title_full | Response to “A clinical trial is a success, not a failure, if it does not demonstrate efficacy or does identify safety concerns,” by Simon Kolstoe, Hugh Davies, and Janet Messer |
| title_fullStr | Response to “A clinical trial is a success, not a failure, if it does not demonstrate efficacy or does identify safety concerns,” by Simon Kolstoe, Hugh Davies, and Janet Messer |
| title_full_unstemmed | Response to “A clinical trial is a success, not a failure, if it does not demonstrate efficacy or does identify safety concerns,” by Simon Kolstoe, Hugh Davies, and Janet Messer |
| title_short | Response to “A clinical trial is a success, not a failure, if it does not demonstrate efficacy or does identify safety concerns,” by Simon Kolstoe, Hugh Davies, and Janet Messer |
| title_sort | response to “a clinical trial is a success, not a failure, if it does not demonstrate efficacy or does identify safety concerns,” by simon kolstoe, hugh davies, and janet messer |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258805/ https://www.ncbi.nlm.nih.gov/pubmed/30511030 http://dx.doi.org/10.1016/j.conctc.2018.10.005 |
| work_keys_str_mv | AT fogeldavidb responsetoaclinicaltrialisasuccessnotafailureifitdoesnotdemonstrateefficacyordoesidentifysafetyconcernsbysimonkolstoehughdaviesandjanetmesser |